Categories: News

Alkame Receives Initial PPE Product Order for Canadian Market

LAS VEGAS, NV / ACCESSWIRE / February 4, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), a publicly traded holding company announced today that that its wholly owned subsidiary, West Coast Co-Packer Inc. has received its initial purchase order from their Canadian Personal Protection Equipment (PPE) distributor Thera Products, Inc. for Alkame’s premium gel-hand sanitizer.

This initial purchase order for the Alkame brand of premium ice blue gel hand sanitizer is for 16.9oz bottles proudly made in the USA in a (cGMP) FDA registered facility in Oregon and contains aloe, menthol, eucalyptus and is gentle on skin. Thera Products anticipates that this purchase order will rapidly expand into additional purchases.

Robert Eakle Alkame CEO states: “These are trying times for everyone and Canada is no exception. We are proud to assist Thera Products and to aid the citizens of Canada to help fight the spread of Corona-19 virus and the new coronavirus variant that is now in Canada.

For inquiries, please email info@westcoastcopacker.com or call #561.573.7200.

About West Coast Co-Packer, Inc.

West Coast Co-Packer, Inc. is a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract packager and is expected to immediately complement and seamlessly integrate with Alkame’s other subsidiaries including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty natural, organic liquid-based hot and cold fill food & beverage manufacturer in glass and PET bottles and jars.

About Alkame Holdings, Inc.

Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company’s wholly owned subsidiaries manufacture products with enhanced water utilizing proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications and placement into several emerging business sectors, such as consumer bottled water and RTD products, liquid hemp products, household pet products, horticulture, agriculture, and medical applications, including hand sanitizers, and many other various water-based treatments solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com.

CONTACT:
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE: Alkame Holdings, Inc.

View source version on accesswire.com:
https://www.accesswire.com/627889/Alkame-Receives-Initial-PPE-Product-Order-for-Canadian-Market

Staff

Recent Posts

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

21 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

21 hours ago